Health Care Equipment & Supplies Companies By Ps Ratio

Price To Sales
Price To SalesEfficiencyMarket RiskExp Return
1GUTS Fractyl Health, Common
9.56 K
(0.03)
 7.83 
(0.27)
2CUPR Cuprina Holdings Limited
3.53 K
(0.02)
 21.54 
(0.34)
3HSCS Heart Test Laboratories
1.5 K
(0.01)
 3.85 
(0.05)
4DXR Daxor
K
 0.14 
 4.17 
 0.58 
5HSDT Helius Medical Technologies
811.45
 0.06 
 19.96 
 1.30 
6DARE Dare Bioscience
751.51
(0.09)
 2.89 
(0.26)
7STSS Sharps Technology
558.89
 0.04 
 11.60 
 0.50 
8BFRG Bullfrog AI Holdings,
400.18
 0.02 
 4.86 
 0.09 
9MGRM Monogram Orthopaedics Common
243.53
 0.16 
 1.32 
 0.21 
10CATX Perspective Therapeutics
164.16
(0.05)
 6.41 
(0.33)
11NXL Nexalin Technology
156.08
 0.10 
 14.69 
 1.41 
12AIMD Ainos Inc
142.01
 0.10 
 6.63 
 0.64 
13COCH Envoy Medical
104.38
(0.01)
 14.12 
(0.09)
14IINN Inspira Technologies Oxy
99.16
(0.12)
 3.83 
(0.45)
15ZTEK ZEN Graphene Solutions
94.74
 0.03 
 6.31 
 0.21 
16SCIE Spectrascience New
73.07
 0.20 
 207.16 
 41.41 
17ACON Aclarion
71.79
 0.06 
 4.33 
 0.25 
18AVR Anteris Technologies Global
65.32
 0.10 
 6.08 
 0.59 
19PLSE Pulse Biosciences
60.23
 0.07 
 3.72 
 0.25 
20AHG Akso Health Group
60.21
 0.00 
 3.97 
(0.01)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.